MS blood samples had more virus and brain antibodies
By MS Buddy ·
Summarized from Proceedings of the National Academy of Sciences of the United States of America, Mar 2025 · PubMed · DOI. AI-generated summary. Not medical advice.
Observational study · 1,311 people with MS and people without MS from the general population
Research by Neda Sattarnezhad, Tobias Lanz and 12 colleagues at Stanford University School of Medicine in the United States.
Do people with MS have different Epstein-Barr virus and brain antibody patterns?
Key Takeaway
People with MS had higher levels of antibodies against an Epstein-Barr virus protein and several proteins in the nervous system than people without MS.

What They Found
Researchers compared blood antibody responses in people with MS and people without MS. Antibody levels against one Epstein-Barr virus protein and three nervous system proteins were higher in the MS group. Lab tests showed that some antibodies reacted to both the virus protein and one nervous system protein. People with MS who carried a gene version linked to MS also had higher levels of these antibodies. Several antibody responses together were linked to higher odds of having MS.
Who Should Care and Why
The study included people with MS and people without MS from the general population. It examined antibodies, which are proteins the immune system makes to recognize targets. The findings may help researchers understand the link between Epstein-Barr virus and MS. They also show that the antibody patterns differed between the two groups. The abstract does not say whether these patterns can diagnose MS.
Important Considerations
The study compared 650 people with MS and 661 people without MS; it did not test a treatment. You cannot tell from this study whether these antibodies cause MS. The abstract does not show whether an antibody test could reliably diagnose MS in an individual.
AI-generated summary — for informational purposes only, not medical advice
Read the original abstract
Published in Proceedings of the National Academy of Sciences of the United States of America by et al.. Reproduced from the PubMed record.
Multiple sclerosis (MS) is an autoimmune demyelinating disorder of the central nervous system (CNS), which is linked to Epstein-Barr virus (EBV) infection, preceding the disease. The molecular mechanisms underlying this connection are only partially understood. We previously described molecular mimicry between the EBV transcription factor EBV nuclear antigen 1 (EBNA1) and three human CNS proteins: anoctamin-2 (ANO2), alpha-B crystallin (CRYAB), and glial cellular adhesion molecule (GlialCAM). Here, we investigated antibody responses against EBNA1 and GlialCAM in a large cohort of 650 MS patients and 661 matched population controls and compared them to responses against CRYAB and ANO2. We confirmed that elevated IgG responses against EBNA1 and all three CNS-mimic antigens associate with increased MS risk. Blocking experiments confirmed the presence of cross-reactive antibodies and molecular mimicry between EBNA1 and GlialCAM, and accompanying antibody responses against adjacent peptide regions of GlialCAM suggest epitope spreading. Antibody responses against EBNA1, GlialCAM, CRYAB, and ANO2 are elevated in MS patients carrying the main risk allele HLA-DRB1*15:01, and combinations of HLA-DRB1*15:01 with anti-EBNA1 and anti-GlialCAM antibodies increase MS risk significantly and in an additive fashion. In addition, antibody reactivities against more than one EBNA1 peptide and more than one CNS-mimic increase the MS risk significantly but modestly. Overall, we show that molecular mimicry between EBNA1 and GlialCAM is likely an important molecular mechanism contributing to MS pathology.
Categories
Explore more research
Related MS research

11/16/2026
A planned study will use detailed brain scans and blood tests to explore why relapsing-remitting MS
Read More
11/15/2026
In tissue from mice with an MS-like disease, a lab drug reduced excess chemical release from nerve e
Read More
11/13/2026
A review compares MS with harmful drug reactions and proposes ways to test how immune genes, lasting
Read More
11/13/2026
This review examines how vitamin D and vitamin A signals shape immune activity in MS and other disea
Read More
11/12/2026
In mice with an MS-like disease, a lab-made protein improved movement and thinking. Researchers also
Read More
11/12/2026
A review proposes how the Epstein-Barr virus might contribute to MS. The model brings earlier ideas
Read MoreNot all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.
